Can IFN-γ be a therapeutic target in Guillain-Barré syndrome? (Q38183432)

30 August 2017

title

Can IFN-γ be a therapeutic target in Guillain-Barré syndrome? (English)

1 reference

30 August 2017

main subject

Guillain–Barré syndrome

0 references

author name string

Hong-Liang Zhang

1

1 reference

30 August 2017

Limin Wu

2

1 reference

30 August 2017

Xiujuan Wu

3

1 reference

30 August 2017

Jie Zhu

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

30 January 2014

1 reference

Expert Opinion on Therapeutic Targets

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

355-363

1 reference

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Pathogenesis of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Regulation of interferon-gamma during innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Cytokines: promoters and dampeners of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

The role of cytokines in Guillain–Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

TH1 and TH2 Response to Campylobacter jejuni Antigen in Guillain-Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Recovery from Guillain-Barré syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Role of cytokines in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Clinical Use of Interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Interactions between CD4 T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4 T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Blood-nerve barrier studies in experimental allergic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

The role of macrophages in immune-mediated damage to the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4 Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

The expression of cytokine mRNA in the cauda equina of Lewis rats with experimental allergic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Restimulation of resting autoreactive T cells by Schwann cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Interferon-gamma in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Modulation of human chondrocyte metabolism by recombinant human interferon gamma: in-vitro effects on basal and IL-1-stimulated proteinase production, cartilage degradation and DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Lymphokines in autoimmunity--a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Acquisition of lymphokine-producing phenotype by CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Demyelination and other neurological adverse events after anti-TNF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

Pathogen-induced Th1 phenotype development in CD4 αβ-TCR transgenic T cells is macrophage dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882899

10.1517/14728222.2014.882899

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference